Nora V. Bergasa

5.7k citations
96 papers · 4.2k indexed · 1 hit paper · h-index 32

Nora V. Bergasa

93 papers receiving 4.1k citations

Hit Papers

Primary biliary cirrhosis # †8092009202620142020250500750

Peers

Nora V. Bergasa
Comparison fields: 5 of 106
  • Hepatology 2.1k
  • Dermatology 1.0k
  • Pharmacology 554
  • Gastroenterology 259
  • Epidemiology 1.6k
Replace J Schölmerich with:
J Schölmerich Germany
G.F. Stefanini Italy
Philip Berry United Kingdom
Peter Ferenci Austria
Hiromi Iwagaki Japan
Preben Olund Kirkegaard Denmark
Esteban Saperas Spain
Full‐Young Chang Taiwan
Michael Yaron Israel
P Attali France
Nora V. Bergasa relative to J Schölmerich Germany J Schölmerich's profile →
Citations per field
00.5×11.5×
J Schölmerich · 1×
Citations per year

Countries citing papers authored by Nora V. Bergasa

Since Specialization
Citations

This map shows the geographic impact of Nora V. Bergasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora V. Bergasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora V. Bergasa more than expected).

Fields of papers citing papers by Nora V. Bergasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora V. Bergasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora V. Bergasa. The network helps show where Nora V. Bergasa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nora V. Bergasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nora V. Bergasa Line = papers co-authored together Nora V. Bergasa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20211
2 20201
3 20202
4 201141
5
Adrenal tumors in patients with chronic hepatitis C.
20100
6 200810
7 200612
8 200613
9 200573
10 20044
11 20044
12 200059
13 199935
14 1999110
15 19986
16 19977
17 199513
18 199491
19 199026
20 198830

About Nora V. Bergasa

Nora V. Bergasa is a scholar working on Hepatology, Pharmacology and Dermatology, having authored 96 papers that have together received 4.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (25 papers), Liver Diseases and Immunity (21 papers), Drug Transport and Resistance Mechanisms (20 papers), Dermatology and Skin Diseases (18 papers), Pharmacological Effects of Natural Compounds (17 papers), Neuropeptides and Animal Physiology (16 papers), Liver Disease and Transplantation (14 papers) and Hepatitis C virus research (11 papers). The work is most often cited by research in Hepatology (2.1k citations), Dermatology (1.0k citations) and Pharmacology (554 citations). Nora V. Bergasa has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include E. Anthony Jones, Anthony E. Jones, Jenny Heathcote, Marshall Kaplan, Keith D. Lindor, Raoul Poupon, Eric M. Gershwin, David W. Alling, John Vergalla and Thomas Talbot. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026